Suresh Gopalan, PhD CEO and Cofounder of ReSurfX, Inc. is an entrepreneur, innovator and executive educated as a mechanical engineer and biotechnologist. ReSurfX is an outcomes intelligence company improving innovation, outcomes and ROI of enterprises from their data-intensive initiatives. Suresh is on a mission to ‘Build an Efficient and Healthy World’ and is currently focused on transforming Pharma, biotech and healthcare through use of tech (with significant emphasis on AI) and strategy.Suresh actively promotes innovation and entrepreneurship including as judge, mentor and committee member for renowned organizations, through blogs on societal impact of technology and regulatory evolution at HiBrow Perspectives. Besides contributing technical and business blogs through company website and invited articles, he releases many of this non-proprietary work and perspectives through other channels..He is a thought, execution and strategy leader with unique skills in conceptualizing complex phenomena to develop practical and scalable technical and business solutions propelling organizations and teams to success. He has improvised approaches for unique team structure as well as approaches to motivate and cater to needs of teams (in the improvised structures and in traditional teams). Having spanned a variety of biological and engineering systems he is skilled at cross-functional interactions across responsibility levels working with the best across disciplines; he has recruited, managed & trained number of professionals in corporate and academic settings.Suresh has over 14 issued patents. Suresh's inventions include the novel data-source agnostic machine learning approach ‘Adaptive Hypersurface Technology’ leveraged by ReSurfX to provide best-in-class software and measurement tech design solutions to market.He is an invited speaker in numerous international conferences, prominent research universities, and entrepreneurship/business forums.The breadth of experiences and accomplishments of Suresh include pioneering contributions to host-pathogen interactions (infection and immunity to bacterial, viral pathogens and co-infections), founding ventures spanning tech, life science & healthcare; inventing a powerful BigData use solutions, antigen and antibody based diagnostic development for infectious disease, phone app for medical adherence, bioprocess & hybridoma technology and molecular genetics (classical thro high-throughput). He is a recipient of fellowships, federal grants with publications in (& reviewer for) reputed journals and books.